180 related articles for article (PubMed ID: 29178985)
1. A complementary role for tetraspanin superfamily member TSSC6 and ADP purinergic P2Y
Makkawi M; Howells D; Wright MD; Jackson DE
Thromb Res; 2018 Jan; 161():12-21. PubMed ID: 29178985
[TBL] [Abstract][Full Text] [Related]
2. A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.
Makkawi M; Moheimani F; Alserihi R; Howells D; Wright M; Ashman L; Jackson DE
Thromb Haemost; 2015 Nov; 114(5):1004-19. PubMed ID: 26245294
[TBL] [Abstract][Full Text] [Related]
3. Impaired "outside-in" integrin alphaIIbbeta3 signaling and thrombus stability in TSSC6-deficient mice.
Goschnick MW; Lau LM; Wee JL; Liu YS; Hogarth PM; Robb LM; Hickey MJ; Wright MD; Jackson DE
Blood; 2006 Sep; 108(6):1911-8. PubMed ID: 16720835
[TBL] [Abstract][Full Text] [Related]
4. A clopidogrel-insensitive inducible pool of P2Y12 receptors contributes to thrombus formation: inhibition by elinogrel, a direct-acting, reversible P2Y12 antagonist.
Haberstock-Debic H; Andre P; Mills S; Phillips DR; Conley PB
J Pharmacol Exp Ther; 2011 Oct; 339(1):54-61. PubMed ID: 21730013
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel: interactions with the P2Y12 receptor and clinical relevance.
Dorsam RT; Murugappan S; Ding Z; Kunapuli SP
Hematology; 2003 Dec; 8(6):359-65. PubMed ID: 14668029
[No Abstract] [Full Text] [Related]
6. P2Y12 Receptor Modulates Sepsis-Induced Inflammation.
Liverani E; Rico MC; Tsygankov AY; Kilpatrick LE; Kunapuli SP
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):961-71. PubMed ID: 27055904
[TBL] [Abstract][Full Text] [Related]
7. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
[TBL] [Abstract][Full Text] [Related]
8. Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
Reiner MF; Akhmedov A; Stivala S; Keller S; Gaul DS; Bonetti NR; Savarese G; Glanzmann M; Zhu C; Ruf W; Yang Z; Matter CM; Lüscher TF; Camici GG; Beer JH
Cardiovasc Res; 2017 Jan; 113(1):61-69. PubMed ID: 28028070
[TBL] [Abstract][Full Text] [Related]
9. Platelet P2Y12 receptors enhance signalling towards procoagulant activity and thrombin generation. A study with healthy subjects and patients at thrombotic risk.
van der Meijden PE; Feijge MA; Giesen PL; Huijberts M; van Raak LP; Heemskerk JW
Thromb Haemost; 2005 Jun; 93(6):1128-36. PubMed ID: 15968399
[TBL] [Abstract][Full Text] [Related]
10. Role of P2Y
Zhang Y; Zhang S; Ding Z
Adv Exp Med Biol; 2017; 906():307-324. PubMed ID: 27628007
[TBL] [Abstract][Full Text] [Related]
11. Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
Delierneux C; Donis N; Servais L; Wéra O; Lecut C; Vandereyken M; Musumeci L; Rahmouni S; Schneider J; Eble JA; Lancellotti P; Oury C
J Thromb Haemost; 2017 May; 15(5):983-997. PubMed ID: 28296036
[TBL] [Abstract][Full Text] [Related]
12. Role of newly formed platelets in thrombus formation in rat after clopidogrel treatment: comparison to the reversible binding P2Y₁₂ antagonist ticagrelor.
Kuijpers MJ; Megens RT; Nikookhesal E; Feijge MA; De Mey JG; oude Egbrink MG; van Giezen JJ; Heemskerk JW
Thromb Haemost; 2011 Dec; 106(6):1179-88. PubMed ID: 22071958
[TBL] [Abstract][Full Text] [Related]
13. Impact of chronic kidney disease on platelet P2Y
Engwenyu LR; Franchi F; Rollini F; Cho JR; DeGroat C; Bhatti M; Alobaidi Z; Ferrante E; Jakubowski JA; Sugidachi A; Zenni M; Bass TA; Angiolillo DJ
Thromb Haemost; 2017 Jan; 117(1):201-203. PubMed ID: 27786340
[No Abstract] [Full Text] [Related]
14. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
[TBL] [Abstract][Full Text] [Related]
15. Ability of the INNOVANCE PFA P2Y system to detect clopidogrel-induced ADP receptor blockade in preangiocath individuals.
McGlasson DL; Shah AD; Fritsma GA
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):583-7. PubMed ID: 21799401
[TBL] [Abstract][Full Text] [Related]
16. The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy.
Stolla M; Stefanini L; Roden RC; Chavez M; Hirsch J; Greene T; Ouellette TD; Maloney SF; Diamond SL; Poncz M; Woulfe DS; Bergmeier W
Blood; 2011 Jan; 117(3):1005-13. PubMed ID: 20971951
[TBL] [Abstract][Full Text] [Related]
17. Platelet ADP receptors contribute to the initiation of intravascular coagulation.
Leon C; Alex M; Klocke A; Morgenstern E; Moosbauer C; Eckly A; Spannagl M; Gachet C; Engelmann B
Blood; 2004 Jan; 103(2):594-600. PubMed ID: 12969982
[TBL] [Abstract][Full Text] [Related]
18. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries.
Andre P; Delaney SM; LaRocca T; Vincent D; DeGuzman F; Jurek M; Koller B; Phillips DR; Conley PB
J Clin Invest; 2003 Aug; 112(3):398-406. PubMed ID: 12897207
[TBL] [Abstract][Full Text] [Related]
19. P2Y12, a new platelet ADP receptor, target of clopidogrel.
Herbert JM; Savi P
Semin Vasc Med; 2003 May; 3(2):113-22. PubMed ID: 15199474
[TBL] [Abstract][Full Text] [Related]
20. P2Y12 protects platelets from apoptosis via PI3k-dependent Bak/Bax inactivation.
Zhang S; Ye J; Zhang Y; Xu X; Liu J; Zhang SH; Kunapuli SP; Ding Z
J Thromb Haemost; 2013 Jan; 11(1):149-60. PubMed ID: 23140172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
